FdaApplication
NDA 021959
Identifiers
- fda_app_no: NDA021959
Properties
| Property | Value |
|---|---|
| applicant_name | ADVANZ PHARMA (US) CORP |
| application_type | NDA |
| approval_date | 2006-06-01 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ORAPRED ODT | PREDNISOLONE SODIUM PHOSPHATE | EQ 30MG BASE | TABLET, ORALLY DISINTEGRATING;ORAL |
| ORAPRED ODT | PREDNISOLONE SODIUM PHOSPHATE | EQ 15MG BASE | TABLET, ORALLY DISINTEGRATING;ORAL |
| ORAPRED ODT | PREDNISOLONE SODIUM PHOSPHATE | EQ 10MG BASE | TABLET, ORALLY DISINTEGRATING;ORAL |
3 products